Subcutaneous drug delivery market size was valued at USD 20.6 billion in the year 2020 and is anticipated to grow at USD 45.53 billion till 2027, witnessing a CAGR of around 12% during the forecast period from 2021 to 2027. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the global subcutaneous drug delivery market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skin’s layer named cutis, which contains the dermis and epidermis. There are several pharmaceutical products developed and sold to treat different illnesses which are given through subcutaneous routes.
The report gives a comprehensive outlook on subcutaneous drug delivery market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of product, distribution Channel and region. This report studies global subcutaneous drug delivery market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global subcutaneous drug delivery.